Romero David V L, Balendran Thivya, Hasang Wina, Rogerson Stephen J, Aitken Elizabeth H, Achuthan Adrian A
Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, 1F Royal Parade, Parkville, VIC, 3010, Australia.
Department of Infectious Diseases, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Sci Rep. 2024 Feb 5;14(1):2949. doi: 10.1038/s41598-024-53519-w.
Plasmodium falciparum infection causes the most severe form of malaria, where excessive production of proinflammatory cytokines can drive the pathogenesis of the disease. Monocytes play key roles in host defense against malaria through cytokine production and phagocytosis; however, they are also implicated in pathogenesis through excessive proinflammatory cytokine production. Understanding the underlying molecular mechanisms that contribute to inflammatory cytokine production in P. falciparum-exposed monocytes is key towards developing better treatments. Here, we provide molecular evidence that histone 3 lysine 4 (H3K4) methylation is key for inflammatory cytokine production in P. falciparum-exposed monocytes. In an established in vitro system that mimics blood stage infection, elevated proinflammatory TNF and IL-6 cytokine production is correlated with increased mono- and tri-methylated H3K4 levels. Significantly, we demonstrate through utilizing a pharmacological inhibitor of H3K4 methylation that TNF and IL-6 expression can be suppressed in P. falciparum-exposed monocytes. This elucidated epigenetic regulatory mechanism, controlling inflammatory cytokine production, potentially provides new therapeutic options for future malaria treatment.
恶性疟原虫感染会引发最严重形式的疟疾,在此过程中促炎细胞因子的过度产生会推动疾病的发病机制。单核细胞通过细胞因子产生和吞噬作用在宿主抵御疟疾中发挥关键作用;然而,它们也会因过度产生促炎细胞因子而参与发病过程。了解导致暴露于恶性疟原虫的单核细胞中炎性细胞因子产生的潜在分子机制是开发更好治疗方法的关键。在此,我们提供分子证据表明组蛋白3赖氨酸4(H3K4)甲基化是暴露于恶性疟原虫的单核细胞中炎性细胞因子产生的关键。在一个模拟血液阶段感染的既定体外系统中,促炎TNF和IL-6细胞因子产生的增加与H3K4单甲基化和三甲基化水平的升高相关。重要的是,我们通过使用H3K4甲基化的药理学抑制剂证明,在暴露于恶性疟原虫的单核细胞中TNF和IL-6的表达可以被抑制。这种阐明的控制炎性细胞因子产生的表观遗传调控机制可能为未来的疟疾治疗提供新的治疗选择。